Three-year Results from the Evolve II Randomized Trial: Late Clinical Outcomes with Bioresorbable Compared to Permanent Polymer Everolimus-eluting

Andrejs Ērglis; Dean J. Kereiakes; Ian Meredith; Stephan Windecker; Josep Rodes-Cabau; Tommy Lee; Arthur Reitman; Mark Dorogy; Barry Bertolet; Louis Cannon

doi:10.1016/S0735-1097(17)34359-0

Three-year Results from the Evolve II Randomized Trial: Late Clinical Outcomes with Bioresorbable Compared to Permanent Polymer Everolimus-eluting

Andrejs Ērglis
, Dean J. Kereiakes
, Ian Meredith
, Stephan Windecker
, Josep Rodes-Cabau
, Tommy Lee
, Arthur Reitman
, Mark Dorogy
, Barry Bertolet
, Louis Cannon

Institute of Cardiology and Regenerative Medicine

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Journal	Journal of the American College of Cardiology
Volume	69
Issue number	11
DOIs	https://doi.org/10.1016/S0735-1097(17)34359-0
Publication status	Published - 2017
Event	66th Annual Scientific Session and Expo of the American College of Cardiology (ACC); Washington, DC, March 17-19, 2017 - Washington, DC, United States Duration: 17 Mar 2017 → 19 Mar 2017 Conference number: 66

OECD Field of Science

3. Medical and Health Sciences

Access to Document

10.1016/S0735-1097(17)34359-0

Cite this

Ērglis, A., J. Kereiakes, D., Meredith, I., Windecker, S., Josep Rodes-Cabau, Lee, T., Reitman, A., Dorogy, M., Bertolet, B., & Louis Cannon (2017). Three-year Results from the Evolve II Randomized Trial: Late Clinical Outcomes with Bioresorbable Compared to Permanent Polymer Everolimus-eluting. Journal of the American College of Cardiology, 69(11). https://doi.org/10.1016/S0735-1097(17)34359-0

@article{e9e7b59b8e3e4b3da0a76bf8743f0fc4,

title = "Three-year Results from the Evolve II Randomized Trial: Late Clinical Outcomes with Bioresorbable Compared to Permanent Polymer Everolimus-eluting",

author = "Andrejs Ērglis and \{J. Kereiakes\}, Dean and Ian Meredith and Stephan Windecker and \{Josep Rodes-Cabau\} and Tommy Lee and Arthur Reitman and Mark Dorogy and Barry Bertolet and \{Louis Cannon\}",

year = "2017",

doi = "10.1016/S0735-1097(17)34359-0",

language = "English",

volume = "69",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier Inc.",

number = "11",

note = "66th Annual Scientific Session and Expo of the American College of Cardiology (ACC); Washington, DC, March 17-19, 2017 ; Conference date: 17-03-2017 Through 19-03-2017",

}

Ērglis, A, J. Kereiakes, D, Meredith, I, Windecker, S, Josep Rodes-Cabau, Lee, T, Reitman, A, Dorogy, M, Bertolet, B & Louis Cannon 2017, 'Three-year Results from the Evolve II Randomized Trial: Late Clinical Outcomes with Bioresorbable Compared to Permanent Polymer Everolimus-eluting', Journal of the American College of Cardiology, vol. 69, no. 11. https://doi.org/10.1016/S0735-1097(17)34359-0

TY - JOUR

T1 - Three-year Results from the Evolve II Randomized Trial: Late Clinical Outcomes with Bioresorbable Compared to Permanent Polymer Everolimus-eluting

AU - Ērglis, Andrejs

AU - J. Kereiakes, Dean

AU - Meredith, Ian

AU - Windecker, Stephan

AU - Josep Rodes-Cabau, null

AU - Lee, Tommy

AU - Reitman, Arthur

AU - Dorogy, Mark

AU - Bertolet, Barry

AU - Louis Cannon, null

N1 - Conference code: 66

PY - 2017

Y1 - 2017

UR - https://www.sciencedirect.com/science/article/pii/S0735109717343590

U2 - 10.1016/S0735-1097(17)34359-0

DO - 10.1016/S0735-1097(17)34359-0

M3 - Meeting abstract

SN - 0735-1097

VL - 69

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 11

T2 - 66th Annual Scientific Session and Expo of the American College of Cardiology (ACC); Washington, DC, March 17-19, 2017

Y2 - 17 March 2017 through 19 March 2017

ER -

Three-year Results from the Evolve II Randomized Trial: Late Clinical Outcomes with Bioresorbable Compared to Permanent Polymer Everolimus-eluting

OECD Field of Science

Access to Document

Other files and links

Cite this